Natco Pharma Ltd.

BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
923.65
5.75 (0.63%)
< Home < Back

NATCO Pharma informs about certificate

Date: 06-04-2024

NATCO Pharma has informed that it enclosed Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations for the quarter ended March 31, 2024.

The above information is a part of company’s filings submitted to BSE.